Search

for
Search:

Research

5 / 1000+ results

research Scientific precision in titles of research papers published in three dermatology journals

2 citations , February 2009 in “Journal of the American Academy of Dermatology”

This study found that many paper titles, especially in the Archives of Dermatology and British Journal of Dermatology, had scientific imprecisions, with "minimization" being the most common.

research CONTRIBUTIONS OF EXPERIMENTAL ANIMAL RESEARCH TO DERMATOLOGY

1 citations , March 1954 in “Archives of dermatology”

This article reviews small animal experiments reported from 1932 to 1952 in two dermatology journals and notes the contributions of Farris's book on laboratory animal care.

research Illustrated synopsis of dermatology and sexually transmitted diseases

14 citations , March 2006 in “TSpace”

This archive discusses the history and purpose of the Bioline International platform for disseminating scholarly research from developing countries, but reports no new research findings.

research The Progress of Epidermal Stem Cell Research

January 2010

This article reviews the current understanding of the localization, characteristics, and potential markers of epidermal stem cells, and reports no new experimental results.

research Madarosis: A dermatological marker

21 citations , January 2008 in “Indian Journal of Dermatology Venereology and Leprology”

This archive describes the Bioline International platform, which hosted open access journals from developing countries but reports no new research findings.

View more "research archives" in research →

Community Join

5 / 1000+ results

community Federal Grant Cuts have impacted PP405 related research

459 upvotes 1 year ago

Federal funding cuts have delayed PP405 research, affecting hair loss treatment progress, though clinical trials will continue. The discussion highlights PP405's potential compared to minoxidil and finasteride and stresses the importance of government-funded research.

community "Clinical efficacy of microneedle combined with 5% Minoxidil solution and finasteride in the treatment of androgenetic alopecia in males"

in Research/Science 64 upvotes 1 year ago

Microneedling combined with 5% Minoxidil and finasteride significantly improves hair growth compared to using Minoxidil or Minoxidil with finasteride alone. The combination treatment is safe and effective, but further research is needed due to small sample size and short study duration.

community If PP405 does revive "dead" hair follicles would DHT blockers theoretically be enough to maintain that new hair

in Research/Science 115 upvotes 11 months ago

PP405 may revive dormant hair follicles, and DHT blockers like finasteride or dutasteride could maintain new hair. Combining PP405 with minoxidil might be optimal, but long-term effects and continuous use are uncertain.

community Fucoidan Treatment Reverses Hair Loss and Inhibits Inflammatory Responses in a Mouse Model of Androgenetic Alopecia

in Research 114 upvotes 1 year ago

Fucoidan may help regrow hair and reduce inflammation in androgenetic alopecia. It is unclear if simply mixing fucoidan powder into a serum for application is effective.

community A miraculous drug that regrows body parts.

in Research/Science 154 upvotes 7 months ago

A drug that regrows body parts, but not hair, sparking debate on hair loss treatments. Discussions include the use of finasteride, dutasteride, and the potential for new methods to restore hair.

View more "research archives" in community →

Learn

7 / 800 results

learn Hair Multiplication

extract, clone, and reinsert your own hair cells

learn Neem Oil

Oil from the neem tree, used in traditional remedies

learn Valproic acid

What should users understand about the distinction between medical research and consumer hair products involving valproic acid? Valproic acid is a prescription anticonvulsant with a boxed warning for liver failure, pancreatitis and harm to an unborn baby, not a cosmetic ingredient. Its hair-growth evidence is laboratory work plus one small trial, and oral valproate itself can cause hair loss.

learn Setipiprant

What side effects or limitations have been reported with Setipiprant use in hair loss research? In the one published hair-loss trial (DuBois 2021; 83 men on setipiprant, 74 on placebo, 24 weeks), setipiprant produced no significant regrowth, and treatment-related side effects were reported in 25.9% on setipiprant vs 12.3% on placebo. It is an unapproved, experimental compound with no long-term safety data.

learn Sulforaphane

What is sulforaphane, and what does research say about scalp and hair follicles? Sulforaphane is a compound from broccoli and related vegetables. Lab and mouse studies suggest effects on follicle cells and on DHT breakdown, but it has not been tested for hair in people.

learn Tofacitinib

How does tofacitinib differ when used orally versus topically in hair loss treatment research? Oral tofacitinib acts on immune signalling throughout the body and has more published regrowth data in alopecia areata (from small studies without placebo groups), alongside an FDA boxed warning; topical tofacitinib aims to act only on the scalp, but the human evidence is a handful of small compounded-formulation studies with no large randomized trial. Neither route is approved for hair loss, and regrowth generally reverses after treatment stops.

learn KX-826

Kintor Pharmaceutical: KX-826, a New Name in Hair Loss Research KX-826 (pyrilutamide) is an experimental topical androgen receptor blocker from Kintor Pharmaceutical and is not approved as a medicine anywhere. Its first China Phase III trial did not beat placebo; the company reported in March 2026 that a later Phase III of a 1.0% formulation met its primary endpoint, but these results are company announcements, not peer-reviewed, and long-term safety is unknown.

View more "research archives" in learn →

Clinics

6 / 14 results

All 14 clinic results →

Experts

— no results

Try a deeper search in experts →